Certified Diabetes Educator Exam 1
Questions and Answers 2026
GoalsBforBaBself-managementBprogramBareBguidedBbyB-BAnswerprogramBphilosophy
AcculturationB-
BAnswertheBprocessBofBculturalBandBpsychologicalBchangeBthatBresultsBfollowingBmeetingBbet
weenBcultures
EnculturationB-
BAnswertheBprocessBbyBwhichBaBpersonBlearnsBtheBrequirementsBofBtheBcultureBbyBwhichBh
eBorBsheBisBsurrounded
AvoidBresistiveBexerciseB-BAnswerESRD,Bnephropathy,BCharcot'sBfoot,BproliferativeBretinopathy
GlipizideB-BAnswershouldBbeBtakenBonBanBemptyBstomach
DrugsBthatBraiseBbloodBglucoseB-
BAnswerClonidine,BCorticosteroids,BCyclosporine,BDiuretic,BEstrogen,BGemfibrozil,BOralBContrace
ptives,BPhenytoinB(Dilantin),BThyroidBHormoneB(Synthroid)
SulfonylureaB+BAspirinB-BAnswerlowersBbloodBglucose
MetforminB+BClonidineB-BAnswerraisesBbloodBglucose
TheBaccuracyBgoalBofBhomeBmetersBisBaBtotalBerrorBofB-BAnswerupBtoB15%
ABbloodBglucoseBmeterBthatBmeasuresBplasmaBbloodBglucoseBinBtheBlaboratoryBwouldBbeB-
BAnswerhigherBthanBaBwholeBbloodBglucoseBreading
DiabetesBControlBandBComplicationBTrialB(DCCT)B-BTypeB1B-
BAnswerIntensiveBbloodBglucoseBreducesBriskBofBeyeBdiseaseBbyB76%,BriskBofBkidneyBdisease
BbyB50%,BnerveBdiseaseBbyB60%
, UnitedBKingdomBProspectiveBDiabetesBStudyB(UKPDS)B-BTypeB2B-
BAnswerEveryBpercentageBpointBdecreaseBinBHgA1c,BthereBwasBaB35%BreductionBinBtheBriskB
ofBmicrovascularBcomplications.
DiabetesBPreventionBProgramB(DPP)B-
BAnswerLifestyleBchangesBwasBmoreBeffectiveBthanBdrugBtherapyB-BweightBlossBofB5-
7%BofBtheirBbodyBweightBandBexerciseBreducedBtheBdevelopmentBofBTypeB2BbyB58%
EpidemiologyBofBDiabetesBInterventionsBandBComplicationsB(EDIC)B-BTypeB1B-BAnswerFollow-
upBstudyBofBDCCTB-
BcardiovascularBdiseaseBeventBwasBreducedBbyB42%BandBnonfatalBheartBattack,Bstroke,BorBde
athBfromBcardiovascularBcausesBwasBreducedBbyB57%BwithBintensiveBbloodBglucoseBcontrol
KetonuriaBinBtheBpresenceBofBeuglycemiaBindicatesB-BAnswerweightBloss
WhenBswitchingBaBpatientBfromBRegularBshort-actingBinsulinBtoBRapidBinsulinBforBtheBpre-
mealBbolus,BweBusuallyBfendBweBneedBtoB-BAnswerincreaseBtheBbasalBdose
WhenBglucagonBisBimpairedBinBTypeB1,BepinephrineBwillBraiseBBGBbyBperformingB2Bprocesses
B-BAnswer1)Bglycogenolysis,B2)BinhibitBglucoseButilizationBbyBinsulinBaction
WhenBepinephrineBbecomesBtheBprimaryBcounter-
regulatoryBhormoneBtoBraiseBbloodBglucoseBinBTypeB2BwhoBisBproducingBinsulin,Bepinephrine
BwillB-BAnswer1)BinhibitBglucoseButilization,B2)BinhibitBendogenousBinsulinBrelease
SulfaBdrugsB+BSulfonylureasB-
BAnswerSulfaBdrugsBtendBtoBincreaseBtheBeffectsBofBSulfonylureasBandBresultBinBhypoglycemia
.
ChildrenBofBpersonsBwithBTypeB1BDiabetesBhaveB-
BAnswer2%BchanceBofBdevelopingBdiabetesBifBmotherBhasBdiabetes,B6%BchanceBofBdevelopin
gBdiabetesBifBfatherBhasBdiabetes
ChildrenBofBpersonsBwithBTypeB2BDiabetesBhaveB-
BAnswer30%BchanceBofBdevelopingBImpairedBGlucoseBToleranceBandB15%BchanceBofBdevelopi
ngBTypeB2BDiabetes
Questions and Answers 2026
GoalsBforBaBself-managementBprogramBareBguidedBbyB-BAnswerprogramBphilosophy
AcculturationB-
BAnswertheBprocessBofBculturalBandBpsychologicalBchangeBthatBresultsBfollowingBmeetingBbet
weenBcultures
EnculturationB-
BAnswertheBprocessBbyBwhichBaBpersonBlearnsBtheBrequirementsBofBtheBcultureBbyBwhichBh
eBorBsheBisBsurrounded
AvoidBresistiveBexerciseB-BAnswerESRD,Bnephropathy,BCharcot'sBfoot,BproliferativeBretinopathy
GlipizideB-BAnswershouldBbeBtakenBonBanBemptyBstomach
DrugsBthatBraiseBbloodBglucoseB-
BAnswerClonidine,BCorticosteroids,BCyclosporine,BDiuretic,BEstrogen,BGemfibrozil,BOralBContrace
ptives,BPhenytoinB(Dilantin),BThyroidBHormoneB(Synthroid)
SulfonylureaB+BAspirinB-BAnswerlowersBbloodBglucose
MetforminB+BClonidineB-BAnswerraisesBbloodBglucose
TheBaccuracyBgoalBofBhomeBmetersBisBaBtotalBerrorBofB-BAnswerupBtoB15%
ABbloodBglucoseBmeterBthatBmeasuresBplasmaBbloodBglucoseBinBtheBlaboratoryBwouldBbeB-
BAnswerhigherBthanBaBwholeBbloodBglucoseBreading
DiabetesBControlBandBComplicationBTrialB(DCCT)B-BTypeB1B-
BAnswerIntensiveBbloodBglucoseBreducesBriskBofBeyeBdiseaseBbyB76%,BriskBofBkidneyBdisease
BbyB50%,BnerveBdiseaseBbyB60%
, UnitedBKingdomBProspectiveBDiabetesBStudyB(UKPDS)B-BTypeB2B-
BAnswerEveryBpercentageBpointBdecreaseBinBHgA1c,BthereBwasBaB35%BreductionBinBtheBriskB
ofBmicrovascularBcomplications.
DiabetesBPreventionBProgramB(DPP)B-
BAnswerLifestyleBchangesBwasBmoreBeffectiveBthanBdrugBtherapyB-BweightBlossBofB5-
7%BofBtheirBbodyBweightBandBexerciseBreducedBtheBdevelopmentBofBTypeB2BbyB58%
EpidemiologyBofBDiabetesBInterventionsBandBComplicationsB(EDIC)B-BTypeB1B-BAnswerFollow-
upBstudyBofBDCCTB-
BcardiovascularBdiseaseBeventBwasBreducedBbyB42%BandBnonfatalBheartBattack,Bstroke,BorBde
athBfromBcardiovascularBcausesBwasBreducedBbyB57%BwithBintensiveBbloodBglucoseBcontrol
KetonuriaBinBtheBpresenceBofBeuglycemiaBindicatesB-BAnswerweightBloss
WhenBswitchingBaBpatientBfromBRegularBshort-actingBinsulinBtoBRapidBinsulinBforBtheBpre-
mealBbolus,BweBusuallyBfendBweBneedBtoB-BAnswerincreaseBtheBbasalBdose
WhenBglucagonBisBimpairedBinBTypeB1,BepinephrineBwillBraiseBBGBbyBperformingB2Bprocesses
B-BAnswer1)Bglycogenolysis,B2)BinhibitBglucoseButilizationBbyBinsulinBaction
WhenBepinephrineBbecomesBtheBprimaryBcounter-
regulatoryBhormoneBtoBraiseBbloodBglucoseBinBTypeB2BwhoBisBproducingBinsulin,Bepinephrine
BwillB-BAnswer1)BinhibitBglucoseButilization,B2)BinhibitBendogenousBinsulinBrelease
SulfaBdrugsB+BSulfonylureasB-
BAnswerSulfaBdrugsBtendBtoBincreaseBtheBeffectsBofBSulfonylureasBandBresultBinBhypoglycemia
.
ChildrenBofBpersonsBwithBTypeB1BDiabetesBhaveB-
BAnswer2%BchanceBofBdevelopingBdiabetesBifBmotherBhasBdiabetes,B6%BchanceBofBdevelopin
gBdiabetesBifBfatherBhasBdiabetes
ChildrenBofBpersonsBwithBTypeB2BDiabetesBhaveB-
BAnswer30%BchanceBofBdevelopingBImpairedBGlucoseBToleranceBandB15%BchanceBofBdevelopi
ngBTypeB2BDiabetes
